|About the author:
||Rodionova V.V., Karasova O.V., Bekh O.E., Tkachenko V.A., Gordiienko Iu.A.
|Type of article
||Idiopathic pulmonary fibrosis is a severe, steadily progressive disease. Lack of specific signs and presence of individual variations in the course of the disease indicate the need to find additional non-invasive markers for diagnosis, estimation of the disease severity and monitoring of treatment effectiveness. Therefore, this study aimed to determine activities of gelatinase A and gelatinase B activities, as well as progelatinase B/lipocalin complex in patients with moderate and severe IPF. It was found that increased gelatinase A and gelatinase B activities correlated with the disease progression. Increased activities of progelatinase B and its active form at different stages of the disease can be used as markers of the severity of the fibrotic process, while gelatinase A activity can indicate its stage. Changes in the progelatinase B/lipocalin complex activity reflect clinical signs and symptoms during the idiopathic pulmonary fibrosis course and are associated with the severity of the disease.
||idiopathic pulmonary fibrosis, gelatinases A and B, progelatinase B/lipocalin complex
- Rodionova VV, Karasyova OV. Vykorystannja pokaznyka trypsynopodibnoi' aktyvnosti krovi jak markera tjazhkosti perebigu legenevogo fibrozu. Medychni perspektyvy. 2018; 23 (2, ch.1): 50-56. [in Ukrainian]
- Shevcova AI, Gordijenko JA, Shaul’s’ka OE, Skoromna AS, inventorsSposib vyznachennja zhelatynaz u plazmi krovi. Ukrayiny patent № 83196. 2013 serpn. 27. [in Ukrainian]
- Feshchenko YI, Gavrysiuk VK, Merenkova YO, Yachnik AI, Leshchenko SI, Liskina IV, et al., editors. Idiopathic pulmonary fibrosis: Clinical features, diagnosis, management (draft national guidelines). Ukrainian Pulmonology Journal. 2013, 3: 26-30 [in Ukrainian]
- Bauvois B, Susin SA. Revisiting Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Cancer: Saint or Sinner? Cancers (Basel). 2018; 10 (9): 336.
- Bchir S, Nasr HB, Bouchet S, Benzarti M, Garrouch A, Tabka Z, et al. Concomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease. J Cell Mol Med. 2017; 21 (7): 1280-1291.
- Bouchet S, Bauvois B. Neutrophil Gelatinase-Associated Lipocalin (NGAL), Pro-Matrix Metalloproteinase-9 (pro-MMP-9) and Their Complex Pro-MMP-9/NGAL in Leukaemias. Cancers (Basel). 2014; 6 (2): 796-812.
- Cataldo D, Munaut C, Noel A, Frankenne F, Bartsch P, Foidart JM, et al. MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol. 2000; 123 (3): 259-267.
- Kasper M, Barth K. Potential contribution of alveolar epithelial type I cells to pulmonary fibrosis. Biosci Rep. 2017; 37 (6): BSR20171301.
- Pardo A, Cabrera S, Maldonado M, Selman M. Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis. Respir Res. 2016; 17: 23.
- Pardo A, Selman M. Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis. Ann Am Thorac Soc. 2016; 13 Suppl 5: S417-S21.
- Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018; 198 (5): e44-e68.
- Tolle LB, Southern BD, Culver DA, Horowitz JC. Idiopathic pulmonary fibrosis: What primary care physicians need to know. Cleve Clin J Med. 2018; 85 (5): 377-386.
- Tran T, Suissa S. The effect of anti-acid therapy on survival in idiopathic pulmonary fibrosis: a methodological review of observational studies. Eur Respir J. 2018; 51 (6): 1800376.
- Upagupta C, Shimbori C, Alsilmi R, Kolb M. Matrix abnormalities in pulmonary fibrosis. Eur Respir Rev. 2018; 27 (148): 180033.
- Wood DW, Downes JJ, Lecks HI. A clinical scoring system for the diagnosis of respiratory failure. Preliminary report on childhood status asthmaticus. Am J Dis Child. 1972; 123 (3): 227-228.
|Publication of the article
||«World of Medicine and Biology» №3(73), 2020 year, 091-096 pages, index UDK 616.24-002.17-021.3-036-074